Saba Capital Management, L.P. sold HQL

January 29, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 11,674 shares of Abrdn Life Sciences Investors at $14.12 per share, a transaction worth $164.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.